Published online Oct 26, 2018. doi: 10.4330/wjc.v10.i10.145
Peer-review started: May 13, 2018
First decision: June 14, 2018
Revised: June 30, 2018
Accepted: August 11, 2018
Article in press: August 11, 2018
Published online: October 26, 2018
Processing time: 165 Days and 17.1 Hours
Endovascular treatment of acute limb ischemia (ALI) is increasingly gaining importance in older and multimorbid patients, compared to conventional surgical techniques. The Rotarex®S debulking system is one such endovascular device, which can be used for catheter-assisted thrombectomy in ALI. However, the use of the 6 French (6F) Rotarex®S system is not generally recommended for crural arteries in the current literature.
Limited data exist to date on the efficacy and safety of the 6F Rotarex®S system for thrombectomy in crural arteries.
Our study aimed to examine whether the 6F Rotarex®S system can be used effectively and safely for endovascular thrombectomy of crural arteries in patients with ALI.
Retrospective analysis of all patients who were referred to our department for endovascular thrombectomy dues to ALI between January 2015 and December 2017.
We identified seven patients who underwent endovascular Rotarex®S catheter thrombectomy in crural arteries due to remaining thrombus formation with no reflow. In two cases, thrombectomy was performed in the anterior tibial artery, in another two cases, in the posterior tibial artery and in the remaining three cases, in the fibular artery. In all seven cases, treatment resulted in restoration of the blood flow to the foot arteries, resolving ischemic symptoms. Vessel dissection or perforation did not occur in any of the seven cases..
Endovascular thrombectomy using the 6F Rotarex®S catheter system may be safe and effective for the treatment of thrombotic occlusion of the proximal and mid portion of crural arteries. In particular, patients with high bleeding risk may profit from such a “mechanical only” treatment option without the need for additional thrombolysis.
Larger prospective trials are necessary in the future to examine the efficacy and safety of the 6F Rotarex®S catheter system in smaller arteries of the lower limb.